Nucl. Acids Res. 43 (W1): W527–W534. doi:10.1093/nar/gkv344
The authors wish to make the following corrections to their article:
In Table 1, the column heading ‘Cell line’ should be replaced by ‘Cell line/Cell type’. In the first line of the table, the ‘human epithelial carcinoma’ cell type is incorrect and should be ‘primary mammalian B lymphocytes’. A new Table 1 is presented below.
Table 1. Comparison of QmRLFS-finder prediction with experimental R-loop detection.
Gene | Cell line/Cell type | Reference | R-loop identification method | R-loop forming signal | RLFS predicted by QmRLFS-finder |
---|---|---|---|---|---|
Immunoglobulin* | Primary mammalian B lymphocytes | (12) | R-loop foot-printing | + | + |
MYC | In vitro | (7,8) | electron microscopy and mutagenic action of AID | + | + |
BCL6 | In vitro | (13) | electron microscopy | + | + |
RHOH | In vitro | (13) | electron microscopy | + | + |
ACTB** | Hela | (14) | DRIP-qPCR | + | + |
FMR1 | Fibroblast/Fragile X Syndrome patient GM03200 | (9,10) | DRIP-qPCR and R-loop foot-printing | + | + |
SNRPN | Ntera2 | (11) | DRIP-seq and R-loop foot printing combined to RNase H digestion | + | + |
HK2 | Ntera2 | (11) | DRIP-seq | + | + |
CHTF8 | Ntera2 | (11) | DRIP-seq | + | + |
CIRH1A | Ntera2 | (11) | DRIP-seq | + | + |
APOE | Ntera2 | (11) | DRIP-seq and R-loop foot-printing combined to RNase H digestion | + | + |
FHIT*** | B-cell | (15) | Overexpressed or knocked down RNase H | + | + |
FLC | Arabidopsis | (18) | DRIP-qPCR and R-loop foot-printing | + | − |
Pkd2l1** | Mouse testes | (17) | DRIP-PCR | + | + |
Foxo4** | Mouse testes | (17) | DRIP-PCR | + | + |
Airn | Mouse embryonic stem cell | (11) | R-loop foot-printing | + | + |
C9orf72 | In vitro | (16) | RNase H digestion | + | + |
JTB | SKOV3 | in-house study | DRIP-qPCR | − | − |
PPMD1 | SKOV3 | in-house study | DRIP-qPCR | − | − |
TP53 | SKOV3 | in-house study | DRIP-qPCR | − | − |
PBX1 | SKOV3 | in-house study | DRIP-qPCR | − | + |
PTEN | SKOV3 | in-house study | DRIP-qPCR | + | + |
+: positive signal; −: negative signal; *switch region; **3′ end; ***fragile site FRA3B on chromosome 3.
The results and conclusion of the article are not affected and remain valid. The authors apologise to the readers for the inconvenience caused.